CoLucid Pharmaceuticals Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
CoLucid Pharmaceuticals (CLCD) IPO Opens Down 15%
May 6, 2015 11:56 AM EDTToday's IPO for CoLucid Pharmaceuticals, Inc. (Nasdaq: CLCD) opened for trading at $8.50 after pricing 5,500,000 shares of common stock at a public offering price of $10.00 per share.
Piper Jaffray & Co. and Stifel are acting as joint book-running managers for the offering.... More
